209 related articles for article (PubMed ID: 23190454)
1. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein.
Lee JH; Cho JH; Yeo J; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
Biologicals; 2013 Mar; 41(2):77-83. PubMed ID: 23190454
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells.
Lee JH; Yeo J; Park HS; Sung G; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
Protein Expr Purif; 2013 Jan; 87(1):17-26. PubMed ID: 23009882
[TBL] [Abstract][Full Text] [Related]
3. Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse.
Doll F; Schwager K; Hemmerle T; Neri D
Arthritis Res Ther; 2013 Sep; 15(5):R138. PubMed ID: 24289726
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis.
Quattrocchi E; Walmsley M; Browne K; Williams RO; Marinova-Mutafchieva L; Buurman W; Butler DM; Feldmann M
J Immunol; 1999 Jul; 163(2):1000-9. PubMed ID: 10395698
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.
Mease PJ; Wei N; Fudman EJ; Kivitz AJ; Schechtman J; Trapp RG; Hobbs KF; Greenwald M; Hou A; Bookbinder SA; Graham GE; Wiesenhutter CW; Willis L; Ruderman EM; Forstot JZ; Maricic MJ; Dao KH; Pritchard CH; Fiske DN; Burch FX; Prupas HM; Anklesaria P; Heald AE
J Rheumatol; 2010 Apr; 37(4):692-703. PubMed ID: 20032102
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody.
Haak-Frendscho M; Marsters SA; Mordenti J; Brady S; Gillett NA; Chen SA; Ashkenazi A
J Immunol; 1994 Feb; 152(3):1347-53. PubMed ID: 8301136
[TBL] [Abstract][Full Text] [Related]
7. Induced production of anti-etanercept antibody in collagen-induced arthritis.
Yi H; Kim J; Jung H; Rim YA; Kim Y; Jung SM; Park SH; Ju JH
Mol Med Rep; 2014 Jun; 9(6):2301-8. PubMed ID: 24718553
[TBL] [Abstract][Full Text] [Related]
8. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
Guo Z; Wang S; Jiao Q; Xu M; Xu Z
Biomed Pharmacother; 2009 Aug; 63(7):537-42. PubMed ID: 18848768
[TBL] [Abstract][Full Text] [Related]
9. A non-innovator version of etanercept for treatment of arthritis.
Maity S; Ullanat R; Lahiri S; Shekar S; Sodhan G; Vyas A; Dyaga G; Ireni S; Nair N; Sotsios Y; Maria DC; Morawala-Patell V
Biologicals; 2011 Nov; 39(6):384-95. PubMed ID: 21996051
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis.
Plessner HL; Lin PL; Kohno T; Louie JS; Kirschner D; Chan J; Flynn JL
J Infect Dis; 2007 Jun; 195(11):1643-50. PubMed ID: 17471434
[TBL] [Abstract][Full Text] [Related]
11. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.
Kaymakcalan Z; Sakorafas P; Bose S; Scesney S; Xiong L; Hanzatian DK; Salfeld J; Sasso EH
Clin Immunol; 2009 May; 131(2):308-16. PubMed ID: 19188093
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of a novel trimerized sTNFRII on acute liver injury.
Luo M; Liu D; Zhang L; Huang S; Yang W; Zhang L; Cui T; Ma H; Wang Z; Sun Q; Xiong C; Zhu J; Li J; Wu X; Jin L; Hu Z; Gao J
Int Immunopharmacol; 2012 May; 13(1):88-92. PubMed ID: 22465962
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.
Taylor L; Bachler M; Duncan I; Keen S; Fallon R; Mair C; McDonald TT; Schwarz H
J Leukoc Biol; 2002 Sep; 72(3):522-9. PubMed ID: 12223520
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.
Mitoma H; Horiuchi T; Tsukamoto H; Tamimoto Y; Kimoto Y; Uchino A; To K; Harashima S; Hatta N; Harada M
Arthritis Rheum; 2008 May; 58(5):1248-57. PubMed ID: 18438840
[TBL] [Abstract][Full Text] [Related]
16. TNF receptor II fusion protein with tandemly repeated Fc domains.
Nagashima H; Kaneko K; Yamanoi A; Motoi S; Konakahara S; Kohroki J; Masuho Y
J Biochem; 2011 Mar; 149(3):337-46. PubMed ID: 21278157
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors.
Eason JD; Wee S; Kawai T; Hong HZ; Powelson JA; Widmer MB; Cosimi AB
Transplantation; 1995 Jan; 59(2):300-5. PubMed ID: 7839455
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
Zhou H
J Clin Pharmacol; 2005 May; 45(5):490-7. PubMed ID: 15831771
[TBL] [Abstract][Full Text] [Related]
19. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
Ashkenazi A; Marsters SA; Capon DJ; Chamow SM; Figari IS; Pennica D; Goeddel DV; Palladino MA; Smith DH
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10535-9. PubMed ID: 1660140
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis.
Zhang L; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang Y; Zhou A; Wei W
Eur J Pharmacol; 2013 May; 708(1-3):113-23. PubMed ID: 23454555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
